The role of imaging in the surveillance of urologic malignancies.
Urologic malignancies are common, accounting for approximately 25% of all new cancer cases in the United States. Patients with urologic malignancies require long-term surveillance to detect progression or recurrence as early as possible. The urologist is faced with the task of balancing patient safety and cost-effectiveness, while finding the most practical follow-up regimen. For each urologic malignancy, this article reviews the commonly used radiologic techniques for surveillance and offers recommended follow-up schedules.
Bradford
Timothy J
TJ
Department of Urology, University of Michigan Medical Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109-0330, USA.
Montie
James E
JE
Hafez
Khaled S
KS
D002292:Carcinoma, Renal Cell / Q000175:diagnosis / Q000628:therapy; D006801:Humans; D007680:Kidney Neoplasms / Q000175:diagnosis / Q000628:therapy; D008279:Magnetic Resonance Imaging; D008297:Male; D011159:Population Surveillance; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000628:therapy; D013736:Testicular Neoplasms / Q000175:diagnosis / Q000628:therapy; D014057:Tomography, X-Ray Computed; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis / Q000628:therapy; D014571:Urologic Neoplasms / Q000175:diagnosis* / Q000628:therapy*